Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

8results about How to "High expression activity" patented technology

Myo6 gene enhancer and application thereof

The invention discloses a Myo6 gene enhancer and application thereof, and belongs to the field of gene engineering. The Myo6 gene enhancer can drive the expression capacity of a reporter gene EGFP or Myo6 gene in the inner ear to be obviously enhanced, can be used for biological materials such as recombinant DNA, vectors or adenoviruses and the like, promotes the expression of the Myo6 gene or other genes in the inner ear so as to carry out gene expression regulation and control research, and is expected to be used for gene therapy of deafness.
Owner:CHENGDU INSTITUTE OF BIOLOGY CHINESE ACADEMY OF SCIENCES

A rhodioloside production strain, a construction method and application thereof

ActiveCN122326502BHigh synthesis efficiencygood synthesis effect
The application provides a rhodioloside production strain and a construction method and application thereof, the strain lacks tyrR, feaB, ldhA, ushA, pykF genes, up-regulates tktA , aroG fbr 、 tyrA fbr、 pgm, galU, gntK the transcription level of a gene, and heterologously introduces a TDC gene from Lactobacillus brevis, a TYO gene from Micrococcus luteus, a ARO10 gene from Saccharomyces cerevisiae, and a ADH6 gene, heterologously introduces a GDH gene from Bacillus and a sugar transferase Oft8gt1 gene from Osmanthus fragrans; the construction method is to reconstruct the metabolic network of Escherichia coli to rhodioloside through metabolic engineering and genetic engineering means, which can effectively utilize glucose to synthesize rhodioloside from scratch, improve the production level of rhodioloside, and lay a solid foundation for the industrialized scale production thereof.
Owner:TIANJIN UNIV OF SCI & TECH

Coagulation factor FVIII protein variants, expression vectors and uses

The present invention provides a coagulation factor FVIII protein variant, an expression vector and a use thereof. The coding nucleic acid sequence of the coagulation factor FVIII protein variant of the present invention is shorter than that of the wild-type coagulation factor FVIII protein, can easily realize the normal packaging of the viral vector, and exhibits enhanced protein expression activity, and has a higher expression amount of the coagulation factor FVIII protein when transferred into cells.
Owner:SUZHOU NGGT BIOTECHNOLOGY CO LTD

A peanut elongation factor EF1α gene promoter, its preparation method and application

This invention belongs to the fields of plant genetic engineering and biotechnology, and discloses a peanut endogenous strong promoter P. AhEF1α Its preparation methods and applications. Promoters include P AhEF1α‑1 P AhEF1α‑2 P AhEF1α‑3 and P AhEF1α‑4 This invention uses the Arabidopsis EF1α gene amino acid sequence as a reference, identifies candidate peanut EF1α genes through homology search, screens high-expression genes by expression level analysis, and clones the aforementioned promoter from the peanut genome of Yuhua 9326 using PCR technology. A recombinant vector containing this promoter is constructed and transformed into peanut embryogenic callus tissue. Functional verification shows that the promoter can efficiently drive the expression of downstream genes in peanut callus. This invention solves the technical bottleneck of existing peanut gene editing technologies that rely on exogenous promoters and have poor adaptability, fills the gap in the application of strong endogenous promoters in peanuts, and can be used to construct a precise gene editing system for peanuts, promoting stress-resistant, high-quality, and grade-equal peanut varieties. It has significant practical value and industrialization prospects.
Owner:HENAN ACAD OF AGRI SCI +1

Use of ENE modulators in modulating plant transposons

The present invention relates to the use of ENE modulators for modulating expression or activity of transposon in plants. It is found for the first time that ENE in a plant can form a triple helix structure with RNA, and a poly-A tail structure can be protected from deadenylation, so that the stability of transposon is enhanced. By deleting ENE, the transposon activity of the transposon can be inhibited. The new discovery of the invention provides a new way for inhibiting the transposon activity of the transposon, is beneficial to reducing the risk of unstable genome caused by transposon activation in the plant breeding process, and increases the controllability of genetic engineering breeding.
Owner:CAS CENT FOR EXCELLENCE IN MOLECULAR PLANT SCI

Saccharomyces cerevisiae culture special for sows in late pregnancy-lactation period and preparation method thereof

PendingCN118956625AImprove functionalityHigh expression activityFungiFood processingWeaningLate gestation
The invention relates to a special saccharomyces cerevisiae culture for sows in the late pregnancy period and the lactation period and a preparation method of the special saccharomyces cerevisiae culture, and the special saccharomyces cerevisiae culture is prepared by adopting saccharomyces cerevisiae HKB-145051 as a fermentation strain and carrying out solid anaerobic fermentation. Food processing byproducts such as palm meal, corncob powder and wheat bran can be used as a culture medium for solid anaerobic fermentation. The saccharomyces cerevisiae culture is rich in dietary fibers, yeast nucleotides and functional polysaccharides, is particularly suitable for breeding sows in the late pregnancy stage and the lactation stage, and can remarkably improve the reproductive capacity of the sows, relieve constipation of the pregnant lactating sows and improve the intestinal development and immunity of piglets before weaning.
Owner:BEIJING UNIV OF AGRI +2

A protein expression vector and a method for enhancing the expression activity of membrane proteins

PendingCN122256389AHigh expression activityhigh activityBacteriaMicroorganism based processesMembrane protein foldingBiochemistry
The present application is based on the principle of protein termination-restart translation of ribosome shift, and provides a cloning method which can be used for improving the expression activity of membrane protein. The method is to construct a start-termination degenerate codon on a protein expression vector, and to restart the protein expression by using the ribosome shift phenomenon after the accidental termination of protein expression, so as to significantly reduce the protein expression rate, provide sufficient time for the folding and anchoring of membrane protein, and significantly improve the cloning method of membrane protein expression activity.
Owner:SUZHOU LEAD BIOTECH CO LTD

Application of Ncgl0030 gene and mutant thereof in promoting synthesis of L-lysine

The invention discloses an application of an Ncgl0030 gene and a mutant of the Ncgl0030 gene in promoting synthesis of L-lysine. The invention provides an application of an Ncgl0030 gene or a biological material related to the Ncgl0030 gene or a mutant gene or a biological material related to the mutant gene in preparation of a product for improving the capacity of microorganisms for producing L-lysine. The invention also provides an application of the Ncgl0030 protein or the mutant protein in production of L-lysine by positively regulating microorganisms. And the Ncgl0030 gene is a gene for coding an Ncgl0030 protein. The mutant gene is a gene for coding mutant protein. The Ncgl0030 protein comprises an amino acid sequence as shown in SEQ ID NO: 2. The mutant protein is the mutant protein of the Ncgl0030 protein. The inventor finds that improvement of the expression activity (point mutation or overexpression) of the Ncgl0030 gene in microorganisms is beneficial to accumulation of L-lysine.
Owner:NINGXIA EPPEN BIOTECH CO LTD